UK markets open in 2 hours 31 minutes

BNP Paribas SA (BNP.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
61.36+0.15 (+0.25%)
At close: 05:35PM CET
Full screen
Previous close61.21
Open61.28
Bid0.00 x 0
Ask0.00 x 0
Day's range61.22 - 61.82
52-week range49.44 - 63.98
Volume2,282,031
Avg. volume2,632,738
Market cap70.265B
Beta (5Y monthly)1.61
PE ratio (TTM)10.03
EPS (TTM)6.12
Earnings date25 Apr 2024
Forward dividend & yield4.60 (7.52%)
Ex-dividend date21 May 2024
1y target est73.00
  • GlobeNewswire

    BNP PARIBAS Group: Share buyback - declaration of transactions in own shares from 11 March to 15 March 2024

    BNP Paribas share buyback programme Declaration of transactions in own sharesfrom March 11, 2024 to March 15, 2024 Press releaseParis, 18 March 2024 In accordance with Article 5 of Regulation (EU) No 596/2014 on Market Abuse and Article 3 (3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditions applicable to buyback programs and stabilization measures, BNP Paribas informs the market of the following tran

  • Bloomberg

    BNP Paribas Considers Buying Fosun’s Ageas Stake

    (Bloomberg) -- BNP Paribas SA is considering a potential acquisition of Fosun International Ltd.’s stake in Belgian insurer Ageas, according to people with knowledge of the matter. Most Read from BloombergA $2 Billion Airport Will Test Modi’s Mission, Adani’s AmbitionsFed Seen Sticking With Three 2024 Cuts Despite Higher InflationBitcoin Extends Retreat From Record as ‘Bubble’ Talk EscalatesApple Buys Canadian AI Startup as It Races to Add FeaturesS&P 500 Falls as $5.3 Trillion Options Test Loom

  • Reuters

    UPDATE 2-Skin care company Galderma announces price range for $2.6 bln flotation

    Skincare company Galderma was on course to raise 2.3 billion ($2.6 billion) Swiss francs from its upcoming initial public (IPO) offering after a positive response from potential investors. The company, whose products includes Cetaphil, a product for damaged and sensitive skin, as well as fillers and skin creams, early on Wednesday announced a price range of 49 to 53 Swiss francs for its flotation - likely to be one of the biggest in Europe this year. The offering consists of up to 40.5 million new shares and 277,000 existing shares, the company said.